Federal State Scientific Institution «Institute of Toxicology Federal Medico-Biological Agency»
Brief summary
In the review are examined the genetic factors, which define the different action’s effects of ethanol for an organism. We’re talking about the meaning of genes which encode ethanol metabolism\'s ferments and receptors for neurotransmitters. Here were examined the polymorphisms genes, their level of expression as an association with risk of various pathological organism’s conditions. After analyzing the data this review we may make a conclusion more likely that reaction of the organism under the ethanol influence are determined genetically. Research for topical areas should include search connection the genetic characteristics with variability of the organism\'s response in acute ethanol intoxication.
3. Bonitenko E.U., Grebenuk A.N., Basharin V.A., Ivanov M.B., Makarova N.V. Ocenka nevrologicheskogo statysa pri ostroi alkogolnoi intoksikacii v eksperimente // Bulleten eksperimentalnoi biologii i medicini. – 2010. – T. 149., № 3. – S. 300–303.
4. Bonitenko U.U. Ostrie otravleniya etanolom i ego syrrogatami. – SPb.: Izd-vo «ELBI-SPB», 2005. – 225 s.
5. Shangareeva Z.A., Viktorova T.V., Nasirov H.M., Sagidyllin A.F., Baikov I.R. Analiz polimorfizma genov ychastvyushih v metabolizme etanola y lic s alkogolnoi boleznu pecheni // Medicinskaya genetika. – 2003. – T. 2, № 11. – S. 485-490.
6. Agarwal D.P. Genetic polymorphisms of alcohol metabolizing enzymes // Pathol. Biol. – 2001. – V. 49, № 9. – P. 703-709.
7. Tabakoff B., Hoffman L. Neirobiologicheskie effekti alkogolya // Voprosi narkologii. – 2003. – № 5. – S. 27–42.
8. Brennan P., Lewis S., Hashibe M. et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck Cancer: a HuGE Review // Am. J. Epidemiol. – 2004. – V. 159, № 1. – P. 1-16.
15. Quertemont, E. Genetic polymorphism in ethanol metabolism: acetaldehyde contribution to alcohol abuse and alcoholism / E. Quertemont // Molecular Psychiatry. – 2004. – V.9. – P. 570–581.
16. Gallelli, L. Pharmacology // L. Gallelli. – In Tech Europe. – 2012. – 720 r.
17. Marysin A.V., Stepanov V.A., Spiridonova M.G., Bohan N.A., Mandel A.I., Harkov V.N., Pels Ya.R., Pyzirev V.P. Polimorfizm genov etanol-metaboliziryushih fermentov ADH1B, ADH7 i CYP2E1, svyaz s riskom razvitiya alkogolizma, komorbidnogo s tyberkylezom, v rysskoi popylyacii Zapadno-Sibirskogo regiona // Medicinskaya genetika. – 2006. – № 7. – S. 51–56.
19. Macgregor S. et al. Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis // Hum. Mol. Genet. – 2009. – V. 18. – P. 580–593.
20. Nagata N., Hiyoshi M., Shiozawa H., Shiraishi K., Watanabe N., Tsuda M., Matsuzaki S. Assessment of a difference in ALDH2 heterozygotes and alcoholic liver injury // Alcohol Clin. Exp. Res. – 2002. – V. 26 (8 Suppl.): – R. 11S–14S.
21. Li D., Zhao H., Gelernter J. Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians // Hum. Genet. – 2012. – № 131. – R. 725–737.
22. Vinogradova S.V. Rol geneticheskih faktorov v razvitii alkogolnoi bolezni pecheni // Sovremennie problemi toksikologii. – 2007. – № 2. – S. 27–37.
23. Ingelman-Sundberg M. Human drug metabolizing cytochrome P450 enzymes: properties and polymorphisms // Naunyn-Schmiedeberg\'s Arch. Pharmacol. – 2004. – V. 369, № 1. – P. 89–104.
24. Pirmohamed M. et al. Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians // Pharmacogenetics. – 1995. – V. 5. – P. 351–357.
25. Watanabe J., Hayashi S., Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to RsaI polymorphism in the 5’ flanking region // J. Biochem. – 1994. – V. 116, № 2. – P. 321–326.
26. Danko I.M., Chaschin N.A. Association of CYP2E1 gene polymorphism with predisposition to cancer development // Exp. Oncol. – 2005. – P. 248–256.
27. Byshma M.I., Zimatkin S M . Ambryshkevich U.G., Legonkova L.F., Byshma T.V., Sheibak B.M. Eksperimentalnii analiz faktorov biologicheskoi predraspolojennosti k razvitiu alkogolnoi bolezni pecheni. / Narkologiya, – 2002. – №4. – S.12-15.
28. Ladero J.M. et al. RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma // Gut. – 1996. – V. 39. – P. 330–333.
35. Kylichkin S.S., Fashytdinova G.G., Kazanceva A.V. i dr. Molekylyarno-geneticheskoe izychenie nasledstvennoi predraspolojennosti k razvitiu hronicheskogo alkogolizma v popylyaciyah yakytov i evenkov respybliki Saha (Yakytiya) // Narkologiya –2012. – T. 11., № 4 (124). – S. 48–55.
36. Kibitov A.O., Anohina I.P. Stryktyrnie osobennosti gena tirozingidroksilazi y bolnih s razlichnoi tyajestu techeniya alkogolizma // Voprosi narkologii – 2002. – №2. – S. 55–65.
37. Johnson B.A., Ait-Daoud, Seneviratne N. et al. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking // Am. J. Psychiatry. – 2011. – V. 168, № 3. – R. 265–275.
38. Vengeliene V., Bilbao A., Molander A., Spanagel R. Neuropharmacology of alcohol addiction // British Journal of Pharmacology. – 2008. – V. 154. – P. 299–315.
39. Faingold C., Li Y., Evans M. S. Decreased GABA and increased glutamate receptor–mediated activity on inferior colliculus neurons in vitro are associated with susceptibility to ethanol withdrawal seizures // Brain Res. – 2000. – Vol. 868, № 2. – p. 287-295.
40. Devaud L.L. Ethanol dependence has limited effects on GABA or glutamate transporters in rat brain // Alcohol Clin. Exp. Res. – 2001. – Vol. 25, № 4. – p. 606-611.
41. Graham A.R. GABAA Receptor channel pharmacology // Current Pharmaceutical Design. – 2005. – V. 11. – P. 1867–1885.
42. Breese G.R., Criswell H.E., Carta M., Dodson P.D. et al. Basis of the gaba mimetic profile of ethanol // Alcohol. Clin. Exp. Res. − 2006. − Vol. 30, № 4. − P. 731−744.
44. Pierucci-Lagha A., Covault J., Feinn R. et al. GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride // Neuropsychopharmacology. –2005. – V.30, №6. – R.1193–1203.
45. Romanenko O.I., Golovko A.I., Shpilenya L.S. i dr. Fynkcionalnoe sostoyanie receptorov glytamata pri vozdeistviyah etanolom // Voprosi medicinskoi himii. – 1999. – №5. – S. 368–374.
46. Longo L.P., Campbell T., Hubatch S. Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention / L.P. Longo, T. Campbell, S. Hubatch, //J. Addict. Dis. – 2002. – V. 21, №. 2. – R. 55–64.
47. Sander T., Ostapowicz A. et al. Genetic variation of the glutamate transporter EAAT2 gene and vulnerability to alcohol dependence // Psychiatry Genet. – 2000. – V. 10, № 3. – R. 103–107.
48. G. Schumann, M. Johann, J. Frank et al. Systematic analysis of glutaminergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior // Arch. Gen. Psychiatry. – 2008. – V. 65, №.7. – R. 826–838.